• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘙痒的治疗:5-羟色胺3型受体拮抗剂的新适应症。

Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.

作者信息

Schwörer H, Ramadori G

机构信息

Zentrum Innere Medizin, Abteilung Gastroenterologie und Endokrinologie, Medizinische Universitätsklinik, Göttingen.

出版信息

Clin Investig. 1993 Aug;71(8):659-62. doi: 10.1007/BF00184497.

DOI:10.1007/BF00184497
PMID:8219665
Abstract

Generalized pruritus is a well-known, distressing symptom of various diseases, especially in hepatic cholestasis and chronic renal insufficiency. Its treatment is often unsatisfactory. In three patients with generalized pruritus, intravenous administration of the serotonin type 3 (5-HT3) receptor antagonist ondansetron induced a marked relief of itching. The effect was most pronounced in a patient with cholestasis-associated pruritus. It is suggested that serotonin, acting via 5-HT3 receptors, is involved in the generation and/or sensation of pruritus. Furthermore, 5-HT3 receptor antagonists may be a novel therapeutic principle for the treatment of pruritus.

摘要

全身性瘙痒是各种疾病中一种广为人知的、令人苦恼的症状,尤其是在肝内胆汁淤积和慢性肾功能不全时。其治疗往往不尽人意。在三名全身性瘙痒患者中,静脉注射5-羟色胺3(5-HT3)受体拮抗剂昂丹司琼可显著缓解瘙痒。这种效果在一名胆汁淤积相关性瘙痒患者中最为明显。提示5-羟色胺通过5-HT3受体发挥作用,参与瘙痒的产生和/或感觉。此外,5-HT3受体拮抗剂可能是治疗瘙痒的一种新的治疗原则。

相似文献

1
Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists.瘙痒的治疗:5-羟色胺3型受体拮抗剂的新适应症。
Clin Investig. 1993 Aug;71(8):659-62. doi: 10.1007/BF00184497.
2
Relief of cholestatic pruritus by a novel class of drugs: 5-hydroxytryptamine type 3 (5-HT3) receptor antagonists: effectiveness of ondansetron.一类新型药物缓解胆汁淤积性瘙痒:5-羟色胺3型(5-HT3)受体拮抗剂:昂丹司琼的有效性
Pain. 1995 Apr;61(1):33-37. doi: 10.1016/0304-3959(94)00145-5.
3
Antipruritic effects of two different 5-HT3 receptor antagonists and an antihistamine in haemodialysis patients.两种不同的5-羟色胺3受体拮抗剂及一种抗组胺药对血液透析患者的止痒作用
Exp Dermatol. 2004 May;13(5):298-304. doi: 10.1111/j.0906-6705.2004.00184.x.
4
Plasma serotonin and histamine levels in hemodialysis-related pruritus are not significantly influenced by 5-HT3 receptor blocker and antihistaminic therapy.血液透析相关性瘙痒患者的血浆血清素和组胺水平不受5-HT3受体阻滞剂和抗组胺治疗的显著影响。
Clin Nephrol. 2003 Feb;59(2):124-9. doi: 10.5414/cnp59124.
5
Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients.组胺和5-羟色胺与尿毒症瘙痒:昂丹司琼对持续性非卧床腹膜透析相关性瘙痒患者的影响
Nephron. 1998;78(4):395-402. doi: 10.1159/000044967.
6
The role of ondansetron in the management of cholestatic or uremic pruritus--a systematic review.恩丹西酮治疗胆汁淤积性或尿毒症性瘙痒的作用——系统评价。
J Pain Symptom Manage. 2012 Nov;44(5):725-30. doi: 10.1016/j.jpainsymman.2011.11.007. Epub 2012 Jun 21.
7
A controlled trial of ondansetron in the pruritus of cholestasis.昂丹司琼治疗胆汁淤积性瘙痒的对照试验。
Aliment Pharmacol Ther. 2005 Apr 15;21(8):1041-5. doi: 10.1111/j.1365-2036.2005.02430.x.
8
Ondansetron therapy for uremic pruritus in hemodialysis patients.昂丹司琼治疗血液透析患者的尿毒症瘙痒症。
Am J Kidney Dis. 2000 May;35(5):827-31. doi: 10.1016/s0272-6386(00)70251-4.
9
Treatment of pruritus in chronic liver disease with the 5-hydroxytryptamine receptor type 3 antagonist ondansetron: a randomized, placebo-controlled, double-blind cross-over trial.5-羟色胺3型受体拮抗剂昂丹司琼治疗慢性肝病瘙痒:一项随机、安慰剂对照、双盲交叉试验
Eur J Gastroenterol Hepatol. 1998 Oct;10(10):865-70. doi: 10.1097/00042737-199810000-00010.
10
Ondansetron and pruritus in chronic liver disease: a controlled study.昂丹司琼与慢性肝病瘙痒:一项对照研究。
Hepatogastroenterology. 2007 Jun;54(76):1196-9.

引用本文的文献

1
Evaluation of Efficacy of Mirtazapine on Pruritus and Serum Histamine and Serotonin Levels in Patients Undergoing Hemodialysis: A Before-After Pilot Clinical Trial.米氮平对血液透析患者瘙痒及血清组胺和5-羟色胺水平的疗效评估:一项前后对照的临床试验。
Int J Nephrol Renovasc Dis. 2020 May 21;13:129-138. doi: 10.2147/IJNRD.S246393. eCollection 2020.
2
Effect of mirtazapine on pruritus in patients on hemodialysis: a cross-over pilot study.米氮平对血液透析患者瘙痒的影响:一项交叉先导研究。
Int Urol Nephrol. 2020 Jun;52(6):1155-1165. doi: 10.1007/s11255-020-02473-3. Epub 2020 May 7.
3
Interventions for chronic pruritus of unknown origin.

本文引用的文献

1
Subhypnotic doses of propofol relieve pruritus associated with liver disease.亚催眠剂量的丙泊酚可缓解与肝病相关的瘙痒。
Gastroenterology. 1993 Jan;104(1):244-7. doi: 10.1016/0016-5085(93)90858-a.
2
Pruritus in hepatic cholestasis. Pathogenesis and therapy.肝内胆汁淤积性瘙痒。发病机制与治疗
Arch Dermatol. 1985 Nov;121(11):1415-20.
3
Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.5-羟色胺M受体亚型的鉴定及其被一类新型药物的特异性阻断
不明原因慢性瘙痒的干预措施。
Cochrane Database Syst Rev. 2020 Jan 25;1(1):CD013128. doi: 10.1002/14651858.CD013128.pub2.
4
Building a 5-HT3A Receptor Expression Map in the Mouse Brain.构建小鼠大脑中的 5-HT3A 受体表达图谱。
Sci Rep. 2017 Mar 9;7:42884. doi: 10.1038/srep42884.
5
Diagnosis and Management of Chronic Pruritus: An Expert Consensus Review.慢性瘙痒的诊断与管理:专家共识综述
Indian J Dermatol. 2017 Jan-Feb;62(1):7-17. doi: 10.4103/0019-5154.198036.
6
Pruritus: management algorithms and experimental therapies.瘙痒:管理算法与实验性疗法
Semin Cutan Med Surg. 2011 Jun;30(2):127-37. doi: 10.1016/j.sder.2011.05.001.
7
Chloroquine-induced Pruritus.氯喹引起的瘙痒。
Indian J Pharm Sci. 2010 May;72(3):283-9. doi: 10.4103/0250-474X.70471.
8
The 5-HT3 receptor as a therapeutic target.5-羟色胺3受体作为一个治疗靶点。
Expert Opin Ther Targets. 2007 Apr;11(4):527-40. doi: 10.1517/14728222.11.4.527.
9
5-HT3 receptors.5-羟色胺3受体
Curr Pharm Des. 2006;12(28):3615-30. doi: 10.2174/138161206778522029.
10
Extrahepatic manifestations of cholestatic liver diseases: pathogenesis and therapy.胆汁淤积性肝病的肝外表现:发病机制与治疗
Clin Rev Allergy Immunol. 2005 Apr;28(2):147-57. doi: 10.1385/CRIAI:28:2:147.
Nature. 1985;316(6024):126-31. doi: 10.1038/316126a0.
4
Pruritus. Current concepts in pathogenesis and treatment.瘙痒症:发病机制与治疗的当前概念
Drugs. 1990 Feb;39(2):218-23. doi: 10.2165/00003495-199039020-00005.
5
Antiemetic control: 5-HT3 antagonists: review of clinical results, with particular emphasis on ondansetron.止吐控制:5-羟色胺3拮抗剂:临床结果综述,尤其侧重于昂丹司琼。
Cancer Treat Rev. 1990 Sep;17(2-3):311-7. doi: 10.1016/0305-7372(90)90063-l.
6
Management of the pruritus of cholestasis: potential role of opiate antagonists.胆汁淤积性瘙痒的管理:阿片类拮抗剂的潜在作用。
Am J Gastroenterol. 1991 Oct;86(10):1404-12.
7
Ondansetron metabolism and pharmacokinetics.昂丹司琼的代谢与药代动力学。
Semin Oncol. 1992 Aug;19(4 Suppl 10):9-15.
8
Pharmacology and preclinical antiemetic properties of ondansetron.
Semin Oncol. 1992 Aug;19(4 Suppl 10):1-8.
9
5-Hydroxytryptamine receptors.5-羟色胺受体
Pharmacol Rev. 1992 Sep;44(3):401-58.